BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38293147)

  • 21. HPV: Molecular pathways and targets.
    Gupta S; Kumar P; Das BC
    Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
    Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor (LEDGF) gene.
    Leitz J; Reuschenbach M; Lohrey C; Honegger A; Accardi R; Tommasino M; Llano M; von Knebel Doeberitz M; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS Pathog; 2014 Mar; 10(3):e1003957. PubMed ID: 24604027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TBX3 Promotes Cervical Cancer Proliferation and Migration via HPV E6 and E7 Signaling.
    Khan SF; Burmeister CA; Scott DJ; Sinkala M; Ramburan A; Wu HT; Schäfer G; Katz AA; Prince S
    Mol Cancer Res; 2023 Apr; 21(4):345-358. PubMed ID: 36622795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies.
    Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK
    Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers.
    Chintala S; Levan J; Robinson K; Quist K; Katzenellenbogen RA
    Onco Targets Ther; 2020; 13():6143-6156. PubMed ID: 32617009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway.
    Cai Y; Huang Y; Zhang J; Liu X; Zhao F; Zhang K; Xu S; Yang Y; Huang H; Gao Y
    Neoplasma; 2022 Dec; 69(6):1406-1417. PubMed ID: 36591804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes.
    Kim M; Kim YS; Kim H; Kang MY; Park J; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Park JK; Cho JW; Shin JK; Choi WS
    Oncotarget; 2016 Jul; 7(28):44596-44607. PubMed ID: 27331873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
    Yang R; Klimentová J; Göckel-Krzikalla E; Ly R; Gmelin N; Hotz-Wagenblatt A; Řehulková H; Stulík J; Rösl F; Niebler M
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30918060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Sui Y; Zhang X; Yang H; Wei W; Wang M
    Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.
    Mahata S; Bharti AC; Shukla S; Tyagi A; Husain SA; Das BC
    Mol Cancer; 2011 Apr; 10():39. PubMed ID: 21496227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression.
    Miller J; Dakic A; Spurgeon M; Saenz F; Kallakury B; Zhao B; Zhang J; Zhu J; Ma Q; Xu Y; Lambert P; Schlegel R; Riegel AT; Liu X
    J Med Virol; 2022 Aug; 94(8):3962-3977. PubMed ID: 35437795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1.
    Hu Z; Cui Y; Zhou Y; Zhou K; Qiao X; Li C; Wang S
    Onco Targets Ther; 2016; 9():6999-7009. PubMed ID: 27895492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.
    Morrison MA; Morreale RJ; Akunuru S; Kofron M; Zheng Y; Wells SI
    J Virol; 2011 Oct; 85(20):10487-98. PubMed ID: 21835799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice.
    Park S; Park JW; Pitot HC; Lambert PF
    mBio; 2016 May; 7(3):. PubMed ID: 27190216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.